BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 19861388)

  • 1. Is there a need for more than one left ventricular lead in some patients?
    Sanaa I; Franceschi F; Prévôt S; Bastard E; Deharo JC
    Europace; 2009 Nov; 11 Suppl 5():v29-31. PubMed ID: 19861388
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lead positioning for cardiac resynchronization therapy: techniques and priorities.
    Morgan JM; Delgado V
    Europace; 2009 Nov; 11 Suppl 5():v22-8. PubMed ID: 19861387
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of long-term resynchronization therapy on left ventricular remodeling in pacemaker patients upgraded to biventricular devices.
    Vatankulu MA; Goktekin O; Kaya MG; Ayhan S; Kucukdurmaz Z; Sutton R; Henein M
    Am J Cardiol; 2009 May; 103(9):1280-4. PubMed ID: 19406272
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of right ventricular lead location on response to cardiac resynchronization therapy in patients with end-stage heart failure.
    Haghjoo M; Bonakdar HR; Jorat MV; Fazelifar AF; Alizadeh A; Ojaghi-Haghjghi Z; Esmaielzadeh M; Sadr-Ameli MA
    Europace; 2009 Mar; 11(3):356-63. PubMed ID: 19136489
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cardiac resynchronization therapy in patients with systolic left ventricular dysfunction and symptoms of mild heart failure secondary to ischemic or nonischemic cardiomyopathy.
    Bleeker GB; Schalij MJ; Holman ER; Steendijk P; van der Wall EE; Bax JJ
    Am J Cardiol; 2006 Jul; 98(2):230-5. PubMed ID: 16828599
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long-term effectiveness of dual site left ventricular cardiac resynchronization therapy in a patient with congestive heart failure.
    Sassara M; Achilli A; Bianchi S; Ficili S; Marullo A; Pontillo D; Achilli P; Peraldo C; Sgreccia F
    Pacing Clin Electrophysiol; 2004 Jun; 27(6 Pt 1):805-7. PubMed ID: 15189538
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dual-site left ventricular cardiac resynchronization therapy.
    Padeletti L; Colella A; Michelucci A; Pieragnoli P; Ricciardi G; Porciani MC; Tronconi F; Hettrick DA; Valsecchi S
    Am J Cardiol; 2008 Dec; 102(12):1687-92. PubMed ID: 19064025
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prevention of disease progression by cardiac resynchronization therapy in patients with asymptomatic or mildly symptomatic left ventricular dysfunction: insights from the European cohort of the REVERSE (Resynchronization Reverses Remodeling in Systolic Left Ventricular Dysfunction) trial.
    Daubert C; Gold MR; Abraham WT; Ghio S; Hassager C; Goode G; Szili-Török T; Linde C;
    J Am Coll Cardiol; 2009 Nov; 54(20):1837-46. PubMed ID: 19800193
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Dual Chamber and VVI Implantable Defibrillator (DAVID) Trial: rationale, design, results, clinical implications and lessons for future trials.
    Wilkoff BL;
    Card Electrophysiol Rev; 2003 Dec; 7(4):468-72. PubMed ID: 15071277
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Early and late effects of cardiac resynchronization therapy on exercise-induced mitral regurgitation: relationship with left ventricular dyssynchrony, remodelling and cardiopulmonary performance.
    Madaric J; Vanderheyden M; Van Laethem C; Verhamme K; Feys A; Goethals M; Verstreken S; Geelen P; Penicka M; De Bruyne B; Bartunek J
    Eur Heart J; 2007 Sep; 28(17):2134-41. PubMed ID: 17504802
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of left ventricular lead position in cardiac resynchronization therapy on left ventricular remodelling. A circumferential strain analysis based on 2D echocardiography.
    Becker M; Kramann R; Franke A; Breithardt OA; Heussen N; Knackstedt C; Stellbrink C; Schauerte P; Kelm M; Hoffmann R
    Eur Heart J; 2007 May; 28(10):1211-20. PubMed ID: 17426079
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of triangle ventricular pacing on haemodynamics and dyssynchrony in patients with advanced heart failure: a comparison study with conventional bi-ventricular pacing therapy.
    Yoshida K; Seo Y; Yamasaki H; Tanoue K; Murakoshi N; Ishizu T; Sekiguchi Y; Kawano S; Otsuka S; Watanabe S; Yamaguchi I; Aonuma K
    Eur Heart J; 2007 Nov; 28(21):2610-9. PubMed ID: 17947217
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rationale and design of a randomized controlled trial to assess the safety and efficacy of cardiac resynchronization therapy in patients with asymptomatic left ventricular dysfunction with previous symptoms or mild heart failure--the REsynchronization reVErses Remodeling in Systolic left vEntricular dysfunction (REVERSE) study.
    Linde C; Gold M; Abraham WT; Daubert JC;
    Am Heart J; 2006 Feb; 151(2):288-94. PubMed ID: 16442890
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Left ventricular dyssynchrony predicts response and prognosis after cardiac resynchronization therapy.
    Bax JJ; Bleeker GB; Marwick TH; Molhoek SG; Boersma E; Steendijk P; van der Wall EE; Schalij MJ
    J Am Coll Cardiol; 2004 Nov; 44(9):1834-40. PubMed ID: 15519016
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long-term effect of cardiac resynchronization therapy on functional mitral valve regurgitation.
    Sitges M; Vidal B; Delgado V; Mont L; Garcia-Alvarez A; Tolosana JM; Castel A; Berruezo A; Azqueta M; Pare C; Brugada J
    Am J Cardiol; 2009 Aug; 104(3):383-8. PubMed ID: 19616672
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Similar long-term benefits conferred by apical versus mid-septal implantation of the right ventricular lead in recipients of cardiac resynchronization therapy systems.
    Bulava A; Lukl J
    Pacing Clin Electrophysiol; 2009 Mar; 32 Suppl 1():S32-7. PubMed ID: 19250108
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of cardiac resynchronization therapy in patients with moderate left ventricular systolic dysfunction and wide QRS complex: a prospective study.
    Fung JW; Zhang Q; Yip GW; Chan JY; Chan HC; Yu CM
    J Cardiovasc Electrophysiol; 2006 Dec; 17(12):1288-92. PubMed ID: 16987381
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Utility of a new left ventricular asynchrony index as a predictor of reverse remodelling after cardiac resynchronization therapy.
    Porciani MC; Lilli A; Macioce R; Cappelli F; Demarchi G; Pappone A; Ricciardi G; Padeletti L
    Eur Heart J; 2006 Aug; 27(15):1818-23. PubMed ID: 16818457
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Importance of contractile reserve for CRT.
    Lim P; Bars C; Mitchell-Heggs L; Roiron C; Elbaz N; Hamdaoui B; Lellouche N; Dubois-Randé JL; Guéret P
    Europace; 2007 Sep; 9(9):739-43. PubMed ID: 17573360
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A randomized comparison of triple-site versus dual-site ventricular stimulation in patients with congestive heart failure.
    Leclercq C; Gadler F; Kranig W; Ellery S; Gras D; Lazarus A; Clémenty J; Boulogne E; Daubert JC;
    J Am Coll Cardiol; 2008 Apr; 51(15):1455-62. PubMed ID: 18402900
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.